Table 2.
Clinical trials.gov number | Drug(s) studied | Phase | Malignancy studied | Status | Estimated completion date |
---|---|---|---|---|---|
NCT01608867 | OMP-54F28 | I | Solid tumors | Recruiting | July 2015 |
NCT02069145 | OMP-54F28 + Sorafenib | Ib | Hepatocellular Cancer | Recruiting | January 2016 |
NCT02092363 | OMP-54F28 + Paclitaxel | Ib | Recurrent Platinum-Sensitive Ovarian Cancer | Recruiting | August 2015 |
NCT02050178 | OMP-54F28 + Nab-Paclitaxel + Gemcitabine | Ib | Metastatic Pancreatic Cancer | Recruiting | December 2015 |